This article describes outcomes in four patients with advanced multiple sclerosis up to two years after autologous haematopoietic stem cell transplantation using a total-body irradiation-based preparative regimen. MRI and C SF analyses demonstrated clear suppression of the inflammatory processes. The results demonstrate however, a dissociation of inflammation parameters and functional disability findings raising questions about optimal future stem cell transplantatio n strategies for this disease.
Kozak T , Havrdova E , Pit’ha J , Gregora E , Pytlik R , Maaloufova Jet al.Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis . Transplant Proceed2001; 33: 2179-2181 .
2.
Burt RK , Cohen BA , Russell E , Spero K , Joshi A , Oyama Yet al.Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of intense immune suppression to prevent disease progression in patients with high disability scores . Blood2003; 102: 2373-2378 .
3.
Fassas A , Anagnostopoulos A , Kazis A , Kapinas K , Sakellari I , Kimiskidis Vet al.Autologous stem cell transplantation in progressive multiple sclerosis-an interim analysis of efficacy . J Clin Immunol2000; 20(1): 24-30 .
4.
Carreras E , Saiz A , Marin P , Martinez C , Rovira M , Villamor Net al.CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year follow-up in 15 patients . Haematologica2003; 88: 306-314 .
5.
Openshaw H , Lund BT , Kashyap A , Atkinson R , Sniecinski I , Weiner LPet al.Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring . Biol Blood Marrow Transplant2000; 6: 563-575 .
6.
Mancardi GL , Saccardi R , Filippi M , Gualandi F , Murialdo A , Inglese Met al.Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS . Neurology2001; 57: 62-68 .
7.
Karussis DM , Slavin S , Lehmann D , Mizrachi-Koll R , Abramsky O , Ben-Nun A.Prevention of experimental auto-immune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation . J Immunol1992; 148: 1693-1698 .
8.
van Gelder M , Kinwel-Bohre EP , van Bekkum DW.Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT . Bone Marrow Transplant1993; 11: 233-241 .
9.
Karussis DM , Slavin S , Ben-Nun A , Ovadia H , Vourka-Karussis U , Lehmann Det al.Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation . J Neuroimmunol1992; 39: 201-210 .
10.
Burt RK , Burns W , Ruvolo P , Fischer A , Shiao C , Guimaraes Aet al.Syngeneic bone marrow transplantation eliminates V(beta) 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis . J Neurosci Res1995; 41: 526-531 .
11.
McAllister LD , Beatty PG , Rose, J.Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis . Bone Marrow Transplant1997; 19: 395-397 .
12.
Tyndall A , Passweg J , Gratwohl A.Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000 . Ann Rheum Dis2001; 60: 702-707 .
13.
Kurtzke JF.Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology1983; 33: 1444-1452 .
Cutter GR , Baier ML , Rudick RA , Cookfair DL , Fischer JS , Petkau Jet al.Development of a multiple sclerosis functional composite as a clinical trial outcome measure . Brain1999; 122: 871-882 .
16.
Nash RA , Bowen JD , McSweeney PA , Pavletic SZ , Maravilla KR , Park MSet al.High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis . Blood2003; 102: 2364-2372 .
17.
Poser CM , Paty DW , Scheinberg L , McDonald WI , Davis FA , Ebers GCet al.New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol1983; 13: 227-231 .
18.
Trapp BD , Peterson J , Ransohoff RM , Rudick R , Mork S , Bo L.Axonal transection in the lesions of multiple sclerosis . N Engl J Med1998; 338: 278-285 .
19.
Tourbah A , Stievenart JL , Gout O , Fontaine B , Liblau R , Lubetzki Cet al.Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis . Neurology1999; 53: 1091-1097 .
20.
Fassas A , Passweg JR , Anagnostopoulos A , Kazis A , Kozak T , Havrdova Eet al.Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study . J Neurol. 2002; 249(8): 1088-1097 .
21.
Muraro PA , Cassiani Ingoni R , Martin R.Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges . Curr Opin Neurol2003; 16: 299-305 .
22.
Murphy CB , Hashimoto SA , Graeb D , Thiessen BA.Clinical exacerbation of multiple sclerosis following radiotherapy . Arch Neurol2003; 60: 273-275 .
23.
Saiz A , Carreras E , Berenguer J , Yague J , Martinez C , Marinet al.MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS . Neurology2001; 56: 1084-1089 .
